Lin et al. [36] further demonstrated that high levels of CXCL8+ macrophages was positively correlated with poor prognosis in patients with gastric cancer and concluded that the administration of CXCL8 inhibitors may result in an effective antitumor response. This evidence concerns the gene CXCL8 and gastric cancer.